文献速递前列腺增生与排尿功能障碍男科与性医学

无针水射流技术精准递送细胞至尿道括约肌复合体

Rapid and precise delivery of cells in the urethral sphincter complex by a novel needle-free waterjet technology.
PubMed 文献 · BJU Int · 2020-10-23

该临床前研究在雌性小型猪尿道括约肌复合体比较无针水射流与William针注射pADSCs的效果。水射流递送更快、定位更精准,所有水射流处理猪尿道均检出形态完整的pADSCs,SRY-PCR与绿色荧光蛋白验证活细胞存在;William针组4头中3头未见细胞或细胞错位,未观察到出血、肿胀或尿潴留等不良事件。

要点

  • 无针水射流可快速、精准地将活pADSCs递送至尿道括约肌复合体
  • 水射流组全部检出形态完整细胞,William针组4头中3头无细胞或错位
  • 未观察到出血、肿胀或尿潴留等不良事件

核心结论

  • 经尿道水射流注射活pADSCs是简单、快速、精准且温和的新技术。
  • 这是首个在临床前体内环境证明水射流可将完整细胞精准注入目标组织的原理验证研究。

研究设计与样本

  • 临床前动物研究:从公猪分离pADSCs,扩增标记后以两种水射流方案注入雌猪括约肌。
  • 孵育15分钟或3天后检查尿道,以William针注射为对照。

主要发现

  • 水射流递送pADSCs比针注射更快且现场精准度更好。
  • 水射流注射期间及之后未见出血、肿胀或尿潴留等不良事件。
  • 所有水射流处理猪尿道均检出形态完整的pADSCs,SRY-PCR与绿色荧光蛋白检测验证活细胞。
  • William针注射的4头猪中3头未见细胞或细胞错位。

临床怎么用

  • 提示无针水射流有望用于压力性尿失禁的细胞治疗递送,但尚需更长随访与尿失禁模型研究。
  • 临床转化前需在尿失禁动物模型中进一步验证疗效与安全性。

局限性

  • 仅为临床前原理验证研究,样本量小。
  • 需更长随访及尿失禁模型研究以探索临床潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the therapy of stress urinary incontinence in a preclinical setting cells were injected into the urethrae of minipigs; however, cells injected by William's needle were frequently misplaced or lost; thus, we investigated if needle-free cell injections using a novel waterjet technology facilitates precise injections in the urethral sphincter complex. MATERIALS AND METHODS: Porcine adipose tissue-derived stromal cells (pADSCs) were isolated from boars, expanded, labelled, and injected in the sphincter of female pigs by waterjet employing two different protocols. After incubation for 15 min or 3 days, the urethrae of the pigs were examined. Injected cells were visualised by imaging and fluorescence microscopy of tissue sections. DNA of injected male cells was verified by polymerase chain reaction (PCR) of the sex-determining region (SRY) gene. Cell injections by William's needle served as controls. RESULTS: The new waterjet technology delivered pADSCs faster and with better on-site precision than the needle injections. Bleeding during or after waterjet injection or other adverse effects, such as swelling or urinary retention, were not observed. Morphologically intact pADSCs were detected in the urethrae of all pigs treated by waterjet. SRY-PCR of chromosomal DNA and detection of recombinant green fluorescent protein verified the injection of viable cells. In contrast, three of four pigs injected by William's needle displayed no or misplaced cells. CONCLUSION: Transurethral injection of viable pADSCs by waterjet is a simple, fast, precise, and yet gentle new technology. This is the first proof-of-principle concept study providing evidence that a waterjet injects intact cells exactly in the tissue targeted in a preclinical in vivo situation. To further explore the clinical potential of the waterjet technology longer follow-up, as well as incontinence models have to be studied.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Linzenbold W, Jäger L, Stoll H, et al. Rapid and precise delivery of cells in the urethral sphincter complex by a novel needle-free waterjet technology. BJU Int. 2020. PMID: 32940408. doi:10.1111/bju.15249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。